D-Herb Will Demonstrate Nutritional Supplement Derived from Galilee Plants for The Aid of Diabetic Patients at ''Biomed 2006''.
"The unique feature of the supplement is that it helps diabetes patients in various stages of the condition, including those who were recently diagnosed and have no treatment history," says Jan Van Mill, CEO. "It is estimated that some 18 million people in the US and 400,000-500,000 in Israel suffer from diabetes, as well as a large number of people who are yet unaware of their illness. So obviously there is a huge market looking for alternatives and treatments that have a confirmed efficacy and are safe to use."
These days the company is seeking a strategic partner for the purpose of marketing in the US. Later on the company plans to start marketing its solution in various markets around the globe. At the same time D-Herb takes the necessary steps to evaluate the supplement for its pharmaceutical potential and get it certified as a medicinal drug.
Established: 2003 Funds: $390,000 through the Chief Scientist Office, 15% in equity capital Founders: Dr. Sobhi Sauob Phase: pre-marketing
The "Biomed 2006" conference and exhibition will be held in the ICC Jerusalem International Convention Center from May 29-31. Keynote speakers and presenters from Israel and abroad will discuss issues and developments in various subjects such as cardiology, the future of healthcare and many more. A special forum will deal with the issue of fund raising in the different industries.
Conference website: http://www.kenes.com/biomed/index.asp
|Printer friendly Cite/link Email Feedback|
|Date:||May 15, 2006|
|Previous Article:||Zend Technologies to Host Second Annual PHP Conference and Expo; October 2006 Event Adds Zend Framework Pavilion.|
|Next Article:||Do-Coop Technologies Announces New Breakthrough Product That Enhances the Stability and Activity of Enzymes; Introduces Neowater(TM) - Enzyme...|